AMRS News and Press, Amyris Inc. From 10/25/22

Amyris and World Wildlife Fund Announce Partnership to Protect Biodiversity PR Newswire EMERYVILLE, Calif. , Oct. 25, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustai...

AMYRIS SUCCESSFULLY LAUNCHES TWO NEW CONSUMER BRANDS PR Newswire EMERYVILLE, Calif. , Oct. 24, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption throu...

One of the more interesting biotech stocks on the scene, next-generation materials maker Amyris (NASDAQ: AMRS) , wasn't very inspiring for investors this week. The company's share price plummeted by 16% over the period, according to data compiled by S&P Global Market Intellige...

Amyris Brands Expanding in UK and Europe. Executing on continued accelerated growth and lower costs PR Newswire EMERYVILLE, Calif. , Oct. 11, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the worl...

Amyris ( NASDAQ: AMRS ) has hit a rough patch over the last two trading sessions as it is down 19% between last Thursday's close and Monday afternoon trading. The stock is down more than 11% today despite no apparent catalysts. Amyris ( AMRS )  is do...

Summary Supply chain issues have massively inflated Amyris’ costs, but many of these issues are resolving themselves. Barra Bonita is an important step towards profitability, but its significance is being vastly overestimated. Insourcing production will help Amyris to c...

Summary Pursuing a horizontal platform strategy before the synthetic biology industry develops creates a risk of insufficient demand. Ginkgo’s ability to capture downstream value is promoted, but companies like Synlogic and Cronos have not inspired confidence so far. Th...

Should You Buy Penny Stocks Now? Are penny stocks worth it? That’s a question that we’ve gotten from a lot of new traders in the stock market today. The topic is becoming even more popular with volatility running rampant and so many well-known names hitting fresh lows. As ...

Summary Amyris' more frequent and larger "exclusivity" deals introduce a unique, recurring catalyst to its business model that enhances profitability and requires raising our earnings estimates. We're raising our EPS estimates from ($1.19) to ($0.22)/share for 2022, from ($0.36) t...

What’s happening on Wall Street in the stock market today? Well, not a lot as the S&P 500, Nasdaq, and Dow chop their way through a dull session. But it isn’t all stocks following suit, and in this article, we discuss several penny stocks outperforming the vast majorit...